China Resources Double-Crane Pharmaceutical Co Ltd Class A 600062
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 21.64
- Day Range
- CNY 21.61–22.04
- 52-Week Range
- CNY 14.80–24.13
- Bid/Ask
- CNY 21.69 / CNY 21.70
- Market Cap
- CNY 22.55 Bil
- Volume/Avg
- 8.4 Mil / 11.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 15.97
- Price/Sales
- 2.15
- Dividend Yield (Trailing)
- 1.34%
- Dividend Yield (Forward)
- 1.34%
- Total Yield
- 1.34%
Company Profile
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 12,269
- Website
- http://www.dcpc.com
Comparables
Valuation
|
Metric
|
600062
|
600557
|
300016
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.97 | 20.49 | — |
Price/Book Value | 1.95 | 2.02 | 1.49 |
Price/Sales | 2.15 | 2.18 | 2.69 |
Price/Cash Flow | 12.22 | 8.16 | 42.20 |
Price/Earnings
600062
600557
300016
Financial Strength
|
Metric
|
600062
|
600557
|
300016
|
|---|---|---|---|
Quick Ratio | 2.08 | 2.19 | 2.84 |
Current Ratio | 2.61 | 2.52 | 3.76 |
Interest Coverage | 114.99 | — | −0.39 |
Quick Ratio
600062
600557
300016
Profitability
|
Metric
|
600062
|
600557
|
300016
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.20% | −2.34% |
Return on Equity (Normalized) | — | 9.86% | −3.88% |
Return on Invested Capital (Normalized) | — | 9.16% | −1.18% |
Return on Assets
600062
600557
300016
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vcjxffmxb | Skvxpy | $78.2 Bil | |
ZTS
| Zoetis Inc Class A | Cfytmrzm | Dkv | $78.0 Bil | |
HLN
| Haleon PLC ADR | Qnccclrq | Lbzj | $38.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vdxzvcwrj | Jgsj | $19.1 Bil | |
VTRS
| Viatris Inc | Fctfjlhg | Rnlk | $12.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zblxtrym | Wcxj | $11.8 Bil | |
CTLT
| Catalent Inc | Rywhdnghx | Wmpnqk | $9.9 Bil | |
PRGO
| Perrigo Co PLC | Wfyjtxr | Hyp | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Bvnkqmhs | Hkjc | $3.5 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wgtxpdvd | Vbtqfh | $3.2 Bil |